AQR Capital Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-20,203
| Closed | -$154K | – | 2315 |
|
|
2016
Q1 | $154K | Buy |
20,203
+7,434
| +58% | +$56.7K | ﹤0.01% | 2143 |
|
|
2015
Q4 | $170K | Buy |
12,769
+6,578
| +106% | +$87.6K | ﹤0.01% | 2177 |
|
|
2015
Q3 | $102K | Buy |
+6,191
| New | +$102K | ﹤0.01% | 2127 |
|
|
2014
Q4 | – | Sell |
-3,833
| Closed | -$44K | – | 2701 |
|
|
2014
Q3 | $44K | Sell |
3,833
-1,034
| -21% | -$11.9K | ﹤0.01% | 2486 |
|
|
2014
Q2 | $95K | Buy |
+4,867
| New | +$95K | ﹤0.01% | 2463 |
|